A resurfaced leaked memo from the Biotechnology Innovation Organization (BIO), first revealed by Brownstone Institute, April 2025, details a $2 million campaign to lobby Congress for Robert F. Kennedy Jr.’s removal as HHS Secretary, highlighting Big Pharma’s ongoing desperation amid his MAHA reforms.
As Kennedy’s regulatory initiative gains momentum, Malone revives an old narrative, revealing the industry’s trepidation about being held accountable. This attempt combines scare tactics and indirect influence to prioritize profits over public health.
Why it matters: The memo highlights Big Pharma’s manipulative hold on health policies. The clash between enormous vaccine profits and Kennedy’s quest for transparency and safety could disrupt a system that relies on shortcuts and silencing reforms as they gather momentum.
The revelation flows into the latest developments, showing how industry panic persists despite months of pushback.
Driving the news: Dr. Malone reposted the memo on X, drawing new attention to BIO’s strategy to lobby against RFK Jr amid Kennedy’s ongoing changes at HHS.
- BIO allocated $2 million for the “Why We Vaccinate” campaign, using “inspire and frighten” tactics to manipulate public and legislative sentiment.
- The plan involves surrogates like Dr. Mehmet Oz and Sen. Bill Cassidy to provide bipartisan cover without engaging Kennedy directly.
- Investors are fleeing the sector due to Kennedy’s “unpredictability,” prompting BIO to commit half its reserves to neutralize him.
These details transition into the background, reminding readers of the memo’s origins.
Catch up quick: The memo, originating from BIO’s April 3, 2025, Vaccine Policy Steering Committee meeting, featured in Malone’s Substack essay “The Plot to Get RFK, Jr.,” portrays it as an attempted “coup” against reform. Kennedy’s MAHA agenda, promoting long-term vaccine data and liability restoration, has unnerved BIO members like Pfizer, leading to this revived strategy amid congressional confrontations.
This context leads into the surprising elements that keep the story alive.
The intrigue: Though the information isn’t new, Malone’s recirculation underscores BIO’s failure to remove Kennedy by September. As reforms like stricter FDA approvals advance, the industry is revealed to have misjudged public backing for MAHA.
This hidden failure segues into the deeper subtext of power struggles.
Between the lines: BIO’s strategy of avoiding direct confrontation and reshaping narratives to imply “efficiency” is fewer safety checks exposes a vulnerable system. This mirrors global attempts, such as WHO treaties, which compromise sovereignty to benefit pharmaceutical interests.
These underlying dynamics naturally flow into voices from key figures.
What they’re saying:
- “A detailed secret trade-association memo plotting the removal of US Secretary of Health and Human Services Robert F. Kennedy, Jr. has leaked. It reads like a coup attempt against regulatory reform—and they are spending millions to make sure Kennedy is out of office by September,” Dr. Robert Malone wrote on X, reposting the April memo to highlight ongoing industry sabotage.
- In his full Substack post, Malone embeds the memo and warns, “This is not a war against misinformation. It’s a war against public transparency in science,” emphasizing BIO’s fear of Kennedy’s reforms exposing their “marketing for medicine” model.
These quotes capture the outrage, leading to the article’s conclusive takeaway.
The bottom line: As Kennedy weathers the storm with MAHA gaining ground—evidenced by recent FDA delays on rushed approvals and growing congressional support—the resurfaced memo may backfire, rallying more allies against Big Pharma’s tactics and accelerating demands for true health reform in a post-trust era.
